Amoxapine in the treatment of depression. A clinical evaluation in ambulant patients.
Amoxapine (Demolox; Lederle), an antidepressive agent, was administered to 24 patients suffering from pathological depression in an open uncontrolled single-blind study. The dosage ranged from 75 to 150 mg/d. Four patients dropped out of the study owing to side-effects and 1 because of rapid improvement. The 19 showed a marked improvement and experienced no side-effects. There were firm indications that improvement can be expected within 7 days.